Total Joint Replacement in the ASC: The Economics of the Fastest Growing Service Line
What total joint replacement in the ASC actually costs, pays and earns, and how to build the pro forma on real numbers.
Total joint replacement in the ASC: the reimbursement rule, the implant cost math, and the case costing method to protect margin on every case.

Total joint replacement in the ASC is the clearest example of where this industry is heading: 560 procedures were added to the Medicare ASC covered procedures list for 2026, 271 of them moved off the inpatient only list, and a new Level 7 musculoskeletal payment classification was built specifically for joints (CMS, November 2025). If your center does not have a hip or knee program yet, your surgeons are being asked about one.
Outpatient total joint replacement is not a new idea. It has been building for several years as techniques, anesthesia protocols and patient selection improved. What changed in 2026 is that Medicare made the economics explicit: a defined payment classification, a phased exit from the inpatient only list, and a payment rule that assumes more joints will move to the ASC setting over the next three years. The clinical question has mostly been answered. The one left is financial: does a joint program make money at your center, at your payer mix, with your implant costs.
Why the rule matters more for joints than for anything else
Most of the 560 procedures added in 2026 are incremental volume for specialties that already operate in ASCs. Joints are different. A single total knee or hip case carries a revenue number, an implant cost and a staffing requirement an order of magnitude larger than a typical ASC case, which means the margin math is far less forgiving of a pricing mistake.
Medicare's broader direction is site neutrality: paying the same rate for the same service no matter where it happens, which structurally favors ASCs because hospital outpatient departments are paid more for the same procedure today (MedPAC). Commercial payers mostly price off the Medicare rate, so as the inpatient only list empties over its three-year phase-out, the question for every joint surgeon's contract is not whether the procedure is covered, but at what rate, and against what implant cost. For a full breakdown of how ASC and hospital outpatient rates differ for the procedures you already do, see ASC vs HOPD: How Reimbursement Differs for the Most Common Procedures.
The number that decides the margin: implants
At the median ASC, supplies run about 26.4% of net revenue; the SIS gold standard is 21.6% of collections, close to $456 a case (Avanza, 2022; SIS, 2019). Orthopedics and spine break that pattern. Because implants are priced per case and vary by vendor, contract and surgeon preference, ortho and spine supply costs commonly run near 30% of revenue, against 12% to 15% for GI or ophthalmology cases (SIS, 2019).
| Group | Supply cost, share of revenue |
|---|---|
| GI and ophthalmology | 12% to 15% |
| Median ASC, all specialties | 26.4% |
| SIS gold standard, all specialties | 21.6% of collections, about $456 a case |
| Orthopedics and spine, implant-heavy cases | near 30% |
| 90th percentile ASC, all specialties | 36.8% |
Apply that spread to a single joint case and the dollars move fast. Take the illustrative case costing example used across our benchmarking work: $2,000 of net revenue, with supplies at the SIS gold standard of 21.6% ($432) and staff labor at 23.5% ($470), before implants, anesthesia and overhead are even added. A total joint case at the median ortho supply ratio of roughly 30% would carry closer to $600 in supplies and drugs before the implant line is counted separately. The difference between running at gold standard and running at the 90th percentile supply ratio, 36.8%, on the same $2,000 case is roughly $300, and a joint program doing even a few hundred cases a year turns that into a six-figure swing with no change in volume or payer rate.
This is why a joint program cannot be priced from an average reimbursement figure. It has to be priced from your actual implant invoice, your actual OR minutes and your actual payer mix, procedure by procedure. The method is the same one we use for every service line: start from collections, capture what was actually consumed rather than what the preference card lists, load labor by minutes, spread fixed cost by room time, then rank contribution margin by procedure and surgeon. We cover the full five-step method on Case Costing for Surgery Centers, and the specialty-by-specialty supply detail, including where ortho and spine diverge from the rest of the center, is in Supply Cost per Case by Specialty: Orthopedics, GI, Ophthalmology and Spine.
Staffing and room time for a joint program
Across all case types, the SIS benchmark for staff hours per case is 14.4 hours, with 14.4 as the average that includes nurses, technicians and administrative staff (SIS, 2019). A total joint case runs longer than that average, which means block time matters more here than almost anywhere else in the center. With 42% of blocked OR time going unused across the average center (HST Pathways, 450+ ASCs, 2024), a joint program built on blocks that are not actually protected for joint-length cases will show a utilization number that looks fine on paper and a schedule that cannot absorb the volume the pro forma assumed.
The fix is the same release-or-lose discipline that applies to every specialty: a published reallocation rule at 48 to 72 hours, utilization tracked by surgeon, and block sized to the actual case length rather than a generic slot. First-case on-time starts matter even more for joints because a late start on a long case pushes the rest of the day, and the median center starts only 64% of first cases on time against a practical floor of 90% (ORBC).
What it costs to build the capacity
Opening or expanding a center to add a joint program means construction at roughly $550 to $850 or more a square foot, with a two-OR single-specialty build running $2 million to $3 million and larger multi-specialty centers $4 million to $8 million (Terrapin Construction Group, 2026), on a timeline of 12 to 24 months from feasibility to first case. Certificate of need adds time in the 35 states plus the District of Columbia that still run some form of CON review, though several exempt ASCs or apply a lighter process (AHPA/NCSL, 2025); confirm your state before the pro forma goes to the bank.
If a management company or platform is involved, management fees commonly run 4% to 7% of net revenue in addition to an equity stake (industry convention, commonly reported), which belongs in the same pro forma line as implant cost and staffing, not treated as a rounding error. Single-specialty centers trade near 5 to 8 times EBITDA and multi-specialty centers 6 to 10 times, with platforms reaching 11 to 17 times (FOCUS Investment Bankers, April 2026), and margin, not revenue, is what moves that multiple. The gap between a 12.8% margin center and a 37.3% margin center (Avanza) is mostly the operational discipline covered in our broader EBITDA benchmarking, in ASC EBITDA Margins: What a Healthy Center Earns and Where the Leaks Are.
Quality reporting is not optional for a joint program
Centers that meet ASC Quality Reporting requirements got a 2.6% payment update for 2026; centers that miss the requirement lose 2.0 percentage points off their update for the year (CMS). A joint program adds infection risk, readmission risk and return-to-OR risk that a GI or ophthalmology case rarely carries, and payers steer joint volume to centers that can prove their outcomes. The quality data belongs in the same packet as your implant cost and contribution margin numbers when you sit down with a payer, a topic covered at the contract level in our comparison of billing and analytics systems that track this data automatically, in ASC Software in 2027: An Honest Comparison of EMR, Billing and Analytics Tools.
What to do this quarter
- Cost your actual joint cases, not an estimate: pull consumption (not the preference card), implant invoice price and OR minutes for every total joint case in the last 12 months, by surgeon, and calculate contribution margin per case.
- Check block protection for joint-length cases specifically: confirm your release-or-lose window is enforced for blocks carrying joint cases, since a program built on 42%-unused block time will not deliver the volume the pro forma assumed.
- Confirm your 2027 rate for every joint code with every commercial payer: do not assume a new covered procedure carries an acceptable rate; price it against your implant cost before you schedule the first case.
Related reading
- Case Costing for Surgery Centers
- ASC vs HOPD: How Reimbursement Differs for the Most Common Procedures
- ASC Software in 2027: An Honest Comparison of EMR, Billing and Analytics Tools
- Supply Cost per Case by Specialty: Orthopedics, GI, Ophthalmology and Spine
- The ASC resource hub: every Sigmatic guide on ambulatory surgery centers
Make your ASC more profitable
Sigmatic is a team of ASC consultants who use our own technology to manage surgery centers: better margins, better workflows, and a real-time view of cost per case and utilization that keeps the gains in place. If the numbers in this article look like your center, book a free 30-minute consultation and we will go through your own figures and show you where the margin is. Read the Case Costing for Surgery Centers guide, grab the free PDF, The 2027 ASC State of the Union: maximizing profit on razor-thin margins, from the form on this page, or email [email protected].
Free guide
The 2027 ASC State of the Union: Maximizing profit on razor-thin margins
16 pages of charts: the market, the 2026 reimbursement rules, the benchmarks that separate a 13 percent margin from a 37 percent one, a case costing method you can run this month and a 90-day plan.
Before you go
Want a more profitable ASC?
Book a free 30-minute consultation on your own numbers, or leave your email and we will send the 2027 guide first.
Make your ASC more profitable.
A free 30-minute consultation on your own numbers: where the margin is, what to fix first. No obligation.